{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:22:18Z","timestamp":1791300138958,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.revmed.2004.06.011","type":"journal-article","created":{"date-parts":[[2004,8,4]],"date-time":"2004-08-04T14:11:17Z","timestamp":1091628677000},"page":"196-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["La neurofibromatose 1 (NF1) ou maladie de Von Recklinghausen"],"prefix":"10.1016","volume":"26","author":[{"given":"S.","family":"Pinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2004.06.011_BIB1","series-title":"The Neurofibromatoses: A Pathogenetic and Clinical Overview","author":"Huson","year":"1994"},{"key":"10.1016\/j.revmed.2004.06.011_BIB2","first-page":"567","article-title":"Pour le r\u00e9seau NF-France. Guidelines for the management of neurofibromatosis 1 - Recommandations de prise en charge de la neurofibromatose 1","volume":"128","author":"Pinson","year":"2001","journal-title":"Ann. Dermatol. Venereol"},{"key":"10.1016\/j.revmed.2004.06.011_BIB3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198112313052704","article-title":"Von Recklinghausen neurofibromatosis","volume":"305","author":"Riccardi","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2004.06.011_BIB4","series-title":"Neurofibromatosis: Phenotype Natural History and Pathogenesis","author":"Riccardi","year":"1992"},{"key":"10.1016\/j.revmed.2004.06.011_BIB5","first-page":"405","article-title":"La maladie de Von Recklinghausen","volume":"119","author":"Zeller","year":"1992","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.revmed.2004.06.011_BIB6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"NIH Concensus Development Conference Neurofibromatosis. Conference statement","volume":"45","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.revmed.2004.06.011_BIB7","first-page":"717","article-title":"The diagnosis of neurofibromatosis 1\u00a0in the child under the age of six years","volume":"143","author":"Obringer","year":"1989","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.revmed.2004.06.011_BIB8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U","article-title":"Type 1\u00a0neurofibromatosis \u2013 a descriptive analysis of the disorder in 1,728\u00a0patients","volume":"70","author":"Friedman","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-3476(95)70159-1","article-title":"Optic pathway tumors in children: the effect of neurofibromatosis type 1\u00a0on clinical manifestations and natural history","volume":"127","author":"Listernick","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.revmed.2004.06.011_BIB10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.410410204","article-title":"Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force","volume":"41","author":"Listernick","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2004.06.011_BIB11","first-page":"125","article-title":"Intellectual impairment in neurofibromatosis 1","volume":"138","author":"Ferner","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.revmed.2004.06.011_BIB12","first-page":"636","article-title":"Revue: Neurofibromatose. Troubles de l'apprentissage: d\u00e9pistage et prise en charge","volume":"3","author":"Nguyen","year":"1997","journal-title":"M\/T"},{"key":"10.1016\/j.revmed.2004.06.011_BIB13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM198604173141603","article-title":"Long-term follow-up of von Recklinghausen neurofibromatosis: survival and malignant neoplasms","volume":"314","author":"Sorensen","year":"1986","journal-title":"N Engl. J. Med"},{"key":"10.1016\/j.revmed.2004.06.011_BIB14","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/1097-0142(19931101)72:9<2746::AID-CNCR2820720936>3.0.CO;2-W","article-title":"Neurofibromatosis type 1\u00a0and childhood cancer","volume":"72","author":"Matsui","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2004.06.011_BIB15","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N","article-title":"Malignant and benign tumors in patients with neurofibromatosis type 1\u00a0in a defined Swedish population","volume":"79","author":"Zoller","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2004.06.011_BIB16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1096-8628(19961202)66:1<7::AID-AJMG2>3.0.CO;2-R","article-title":"Neurofibromatosis type 1\u00a0and pregnancy","volume":"66","author":"Dugoff","year":"1996","journal-title":"Am. J. Med. Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB17","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archderm.1996.03890350075012","article-title":"Usefulness of screening investigations in neurofibromatosis type 1: a study of 152\u00a0patients","volume":"132","author":"Wolkenstein","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2004.06.011_BIB18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1\u00a0and neurofibromatosis 2","volume":"278","author":"Gutmann","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2004.06.011_BIB19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0140-6736(98)00155-X","article-title":"What level of care for the neurofibromatoses?","volume":"353","author":"Huson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0190-9622(97)70182-8","article-title":"Guideline of care for neurofibromatosis type 1. J","volume":"37","author":"Eichenfield","year":"1997","journal-title":"Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2004.06.011_BIB21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jmg.29.12.841","article-title":"A genetic study of type 2\u00a0neurofibromatosis in the United Kingdom: Prevalence, mutation rate, and confirmation of maternal transmission effect on severity","volume":"29","author":"Evans","year":"1992","journal-title":"J. Med. Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB22","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/jmg.28.11.752","article-title":"Watson syndrome: Is it a subtype of type 1\u00a0neurofibromatosis?","volume":"28","author":"Allanson","year":"1991","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/hmg\/1.9.735","article-title":"Analysis of mutations at the neurofibromatosis 1 (NF1) locus","volume":"1","author":"Upadhyaya","year":"1992","journal-title":"Hum. Molec. Genet."},{"key":"10.1016\/j.revmed.2004.06.011_BIB24","first-page":"90","article-title":"Tandem duplication within a neurofibromatosis type I (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome","volume":"53","author":"Tassabehji","year":"1993","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ajmg.1320450518","article-title":"Autosomal dominant multiple caf\u00e9 au lait spots and neurofibromatosis type l: evidence of non-linkage","volume":"45","author":"Charrow","year":"1993","journal-title":"Am. J. Med. Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB26","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajmg.1320460428","article-title":"Exclusion of the neurofibromatosis 1\u00a0locus in a family with inherited caf\u00e9 au lait spots","volume":"46","author":"Brunner","year":"1993","journal-title":"Am. J. Med. Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/jmg.32.12.985","article-title":"Familial caf\u00e9 au lait spots: a variant of neurofibromatosis type 1","volume":"32","author":"Abeliovich","year":"1995","journal-title":"J. Med. Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1294-357","article-title":"Mapping a gene for Noonan syndrome to the long arm of chromosome 12","volume":"8","author":"Jamiesson","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1399-0004.1996.tb04328.x","article-title":"Neurofibromatosis\/Noonan phenotype: a variable feature of type 1\u00a0Neurofibromatosis","volume":"49","author":"Colley","year":"1996","journal-title":"Clin. Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1098-1004(1996)8:1<51::AID-HUMU7>3.0.CO;2-S","article-title":"Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome","volume":"8","author":"Wu","year":"1996","journal-title":"Hum. Mutat"},{"issue":"8","key":"10.1016\/j.revmed.2004.06.011_BIB32","first-page":"623","article-title":"Revue\u00a0: Neurofibromatose. G\u00e9n\u00e9tique et physiopathologie mol\u00e9culaire de la NF1","volume":"3","author":"Bahuau","year":"1997","journal-title":"M\/T"},{"key":"10.1016\/j.revmed.2004.06.011_BIB33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jmg.33.1.2","article-title":"Molecular genetics of neurofibromatosis type 1 (NF1)","volume":"33","author":"Shen","year":"1996","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.revmed.2004.06.011_BIB34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0092-8674(87)90534-4","article-title":"Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene","volume":"49","author":"Seizinger","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2004.06.011_BIB35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1\u00a0neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.revmed.2004.06.011_BIB36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1\u00a0locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2004.06.011_BIB37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0888-7543(90)90199-5","article-title":"Identification and characterization of transcripts from the neurofibromatosis 1\u00a0region: the sequence and genomic structure of EVI2 and mapping of other transcripts","volume":"7","author":"Cawthon","year":"1990","journal-title":"Genomics"},{"key":"10.1016\/j.revmed.2004.06.011_BIB38","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0888-7543(91)90410-G","article-title":"cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1\u00a0gene","volume":"9","author":"Cawthon","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.revmed.2004.06.011_BIB39","first-page":"906","article-title":"The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1\u00a0gene","volume":"11","author":"Viskochil","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.revmed.2004.06.011_BIB40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0888-7543(92)90122-9","article-title":"Characterisation of human adenylate cyclase 3 (AK3) cDNA and mapping of the AK3 pseudogene in an intron of the NF1 gene","volume":"3","author":"Xu","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.revmed.2004.06.011_BIB41","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1073\/pnas.88.22.9914","article-title":"Identification and characterization of the neurofibromatosis type 1\u00a0protein product","volume":"88","author":"DeClue","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2004.06.011_BIB42","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1073\/pnas.88.21.9658","article-title":"Identification of the neurofibromatosis type 1\u00a0gene product","volume":"88","author":"Gutman","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2004.06.011_BIB43","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1086\/302809","article-title":"Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain","volume":"66","author":"Fahsold","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB44","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.276.5313.795","article-title":"Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides","volume":"276","author":"Guo","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.revmed.2004.06.011_BIB45","first-page":"487","article-title":"A conserved alternative splice in the Von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity","volume":"13","author":"Andersen","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.revmed.2004.06.011_BIB46","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/hmg\/2.7.989","article-title":"An alternatively-spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle","volume":"2","author":"Gutmann","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB47","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/hmg\/4.5.915","article-title":"Neurofibromatosis 1 (NF1)) mRNAs expressed in the central nervous system are differently spliced in the 5' part of the gene","volume":"4","author":"Danglot","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB48","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/hmg\/6.10.1707","article-title":"RNA processing and clinical variability in neurofibromatosis type I (NF1)","volume":"6","author":"Skuse","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1086\/337952","article-title":"C\u00e0U editing of neurofibromatosis 1\u00a0mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme","volume":"70","author":"Mukhopadhyay","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB50","first-page":"65","article-title":"The mutational spectrum in neurofibromatosis 1\u00a0and its underlying mechanisms","author":"Upadhyaya","year":"1998","journal-title":"Neurofibromatosis type 1: from genotype to phenotype. Bios scientific publishers"},{"key":"10.1016\/j.revmed.2004.06.011_BIB51","first-page":"57","article-title":"The NF1 Genetic Analysis Consortium","author":"Korf","year":"1998","journal-title":"Neurofibromatosis type 1: from genotype to phenotype. Bios scientific publishers"},{"key":"10.1016\/j.revmed.2004.06.011_BIB52","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/hmg\/10.13.1387","article-title":"Recombination hotspot in NF1 microdeletion patients","volume":"10","author":"Lopez-Correa","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB53","first-page":"194","article-title":"Segmental neurofibromatosis: report of two cases and critical review of the literature","volume":"4","author":"Combemale","year":"1994","journal-title":"Eur. J. Derma."},{"key":"10.1016\/j.revmed.2004.06.011_BIB54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2133.1994.tb06893.x","article-title":"What is segmental neurofibromatosis?","volume":"130","author":"Moss","year":"1994","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.revmed.2004.06.011_BIB55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ajmg.1320590427","article-title":"Deletion of the entire NF1 gene detected by FISH: Four deletion patients associated with severe manifestations","volume":"59","author":"Wu","year":"1995","journal-title":"Am. J. Med. Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB56","first-page":"305","article-title":"An analysis of variation in expression of neurofibromatosis (NF) type I (NF1): evidence for modifying genes","volume":"53","author":"Easton","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.revmed.2004.06.011_BIB57","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/356713a0","article-title":"Aberrant regulation of ras proteins in malignant tumour cells from type 1\u00a0neurofibromatosis patients","volume":"356","author":"Basu","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2004.06.011_BIB58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0092-8674(92)90407-4","article-title":"Abnornal regulation of mammalian p2lras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis","volume":"69","author":"DeClue","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2004.06.011_BIB59","first-page":"33","article-title":"malignancy in neurofibromatosis","volume":"29","author":"Hope","year":"1991","journal-title":"Adv Neurol"},{"key":"10.1016\/j.revmed.2004.06.011_BIB60","first-page":"305","article-title":"Malignancy: epidemiology associated cancers","author":"Mulvihill","year":"1994"},{"key":"10.1016\/j.revmed.2004.06.011_BIB61","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1212\/WNL.45.10.1897","article-title":"Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity","volume":"45","author":"Molloy","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2004.06.011_BIB62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0022-3476(95)70159-1","article-title":"Optic pathways in children: the effect of neurofibromatosis type 1\u00a0on clinical manifestations and natural history","volume":"127","author":"Listernick","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.revmed.2004.06.011_BIB63","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/bjc.1991.216","article-title":"An estimate heritable fraction of childhood cancer","volume":"63","author":"Narod","year":"1991","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.revmed.2004.06.011_BIB64","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/gcc.2870040411","article-title":"Loss of NF1 alleles in phaeochrocytomas from patients with type 1\u00a0neurofibromatosis","volume":"4","author":"Xu","year":"1992","journal-title":"Genes Chrom Cancer"},{"key":"10.1016\/j.revmed.2004.06.011_BIB65","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/gepi.1370120504","article-title":"Association of childhood rhabdomyosarcoma with neurofibromatosis type 1\u00a0and birth defects","volume":"13","author":"Yang","year":"1995","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.revmed.2004.06.011_BIB66","first-page":"152","article-title":"Neurofibrosarcoma as a complication of von Recklinghausen neurofibromatosis","volume":"2","author":"Riccardi","year":"1989","journal-title":"Neurofibromatosis"},{"key":"10.1016\/j.revmed.2004.06.011_BIB67","first-page":"36","article-title":"Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome and acute leukemia associated with neurofibromatosis","volume":"3","author":"Kaneto","year":"1989","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2004.06.011_BIB68","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1182\/blood.V79.5.1311.1311","article-title":"Monosomy 7\u00a0myeloproliferative disease in children with neurofibromatosis type 1: epidemiology and molecular analysis","volume":"79","author":"Shannon","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2004.06.011_BIB69","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199403033300903","article-title":"Loss of the normal allele from the bone marrow of children with type 1\u00a0neurofibromatosis and malignant myeloid disorders","volume":"330","author":"Shannon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2004.06.011_BIB70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/gcc.2870030111","article-title":"Molecular and cytogenetic analysis of tumors in Von Reckinghausen neurofibromatosis","volume":"3","author":"Glover","year":"1991","journal-title":"Genes Chrom Cancer"},{"key":"10.1016\/j.revmed.2004.06.011_BIB71","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1073\/pnas.87.14.5435","article-title":"Chromosome 17p deletions and P53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis","volume":"87","author":"Menon","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2004.06.011_BIB72","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/BF00220476","article-title":"Molecular characterization of a 17q11.2 translocation in a malignant schwannoma cell line","volume":"90","author":"Reynolds","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB73","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2004.06.011_BIB74","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1073\/pnas.90.12.5539","article-title":"Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP-Ras","volume":"90","author":"Johnson","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2004.06.011_BIB75","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0092-8674(92)90408-5","article-title":"Somatic mutations in the neurofibromatosis type 1\u00a0gene in human tumors","volume":"69","author":"Li","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2004.06.011_BIB76","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","article-title":"Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells","volume":"12","author":"Bollag","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ng0296-137","article-title":"Nf1 deficiency causes Ras-mediated granulocyte\/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukemia","volume":"12","author":"Largaespada","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB78","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB79","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1101\/gad.8.9.1019","article-title":"Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues","volume":"8","author":"Brannan","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.revmed.2004.06.011_BIB80","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0092-8674(95)90470-0","article-title":"Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons","volume":"82","author":"Vogel","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2004.06.011_BIB81","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1126\/science.286.5447.2176","article-title":"Mouse tumor model for neurofibromatosis type 1","volume":"286","author":"Vogel","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.revmed.2004.06.011_BIB82","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1126\/science.286.5447.2172","article-title":"Mouse models of tumor development in neurofibromatosis type 1","volume":"286","author":"Cichowski","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.revmed.2004.06.011_BIB83","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ng0397-281","article-title":"A mouse model for the learning and memory deficits associated with neurofibromatosis type I","volume":"15","author":"Silva","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB84","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1097-4547(20000901)61:5<524::AID-JNR7>3.0.CO;2-Z","article-title":"Long-term culture and characterization of human neurofibroma-derived Schwann cells","volume":"61","author":"Rosenbaum","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.revmed.2004.06.011_BIB85","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ng0996-110","article-title":"Identification of NF1 mutations in both alleles of a dermal neurofibroma","volume":"14","author":"Sawada","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB86","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","article-title":"Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations","volume":"9","author":"Serra","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2004.06.011_BIB87","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1172\/JCI7610","article-title":"Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models","volume":"105","author":"DeClue","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2004.06.011_BIB88","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.onc.1201978","article-title":"Expression of Kit in neurofibromin-deficient human Schwann cells: role inSchwann cell hyperplasia associated with type 1\u00a0neurofibromatosis","volume":"17","author":"Badache","year":"1998","journal-title":"Oncogene"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866304002437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866304002437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:13:22Z","timestamp":1759335202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866304002437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0248866304002437"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2004.06.011","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La neurofibromatose 1 (NF1) ou maladie de Von Recklinghausen","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2004.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}